Utah Retirement Systems - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 360 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
Utah Retirement Systems ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q2 2024$1,703,502
-12.5%
64,600
+0.8%
0.02%
-13.0%
Q1 2024$1,946,717
+7.9%
64,100
-0.2%
0.02%0.0%
Q4 2023$1,803,378
+4.1%
64,200
+0.6%
0.02%
-8.0%
Q3 2023$1,731,532
-11.4%
63,800
+0.3%
0.02%
-7.4%
Q2 2023$1,955,064
-18.2%
63,600
-4.1%
0.03%
-22.9%
Q1 2023$2,388,789
-8.8%
66,3000.0%0.04%
-16.7%
Q4 2022$2,620,176
-0.7%
66,300
+0.9%
0.04%
-4.5%
Q3 2022$2,639,000
-4.1%
65,700
+0.3%
0.04%0.0%
Q2 2022$2,753,000
+21.9%
65,500
+12.9%
0.04%
+46.7%
Q1 2022$2,259,000
-3.9%
58,000
-1.7%
0.03%
+3.4%
Q4 2021$2,351,000
+10.6%
59,000
+0.3%
0.03%0.0%
Q3 2021$2,125,000
-15.8%
58,800
-4.5%
0.03%
-12.1%
Q2 2021$2,525,000
-5.7%
61,600
+0.3%
0.03%
-10.8%
Q1 2021$2,678,000
+153.6%
61,400
+191.0%
0.04%
+146.7%
Q4 2020$1,056,00021,1000.02%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2023
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$263,446,00059.92%
Memorial Sloan Kettering Cancer Center 1,128,255$43,957,00050.90%
Vantage Consulting Group Inc 2,727,854$106,277,00041.47%
Indie Asset Partners, LLC 756,874$29,488,00022.15%
Overbrook Management Corp 723,250$28,178,0006.25%
Brown University 621,759$24,224,0005.93%
Geo Capital Gestora de Recursos Ltd 200,692$8,527,0003.82%
Lagoda Investment Management, L.P. 141,560$5,515,0002.97%
Greytown Advisors Inc. 131,143$5,109,0002.47%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,025,610$78,918,0002.41%
View complete list of ROYALTY PHARMA PLC shareholders